Optimizing the first-line fertility treatment

被引:4
|
作者
Irani, Mohamad [1 ]
Chow, Stephen [1 ]
Keating, Derek [1 ]
Elder, Simone [2 ]
Rosenwaks, Zev [1 ]
Palermo, Gianpiero [1 ]
机构
[1] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med, New York, NY USA
关键词
Clomiphene citrate; endometrial thickness; follicle; intrauterine insemination; total motile spermatozoa; INTRAUTERINE INSEMINATION; SPERM MORPHOLOGY; ENDOMETRIAL THICKNESS; PREDICTIVE-VALUE; PREGNANCY; INFERTILITY; MANAGEMENT; PROGNOSIS; NUMBER; IUI;
D O I
10.1080/09513590.2018.1441825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to identify sperm score thresholds to achieve satisfactory intrauterine insemination (IUI) success rates according to the response to stimulation with clomiphene citrate (CC). To minimize the confounding effect of female age, we included only CC/IUI cycles of women 35years old. A total of 1,194CC/IUI cycles were included. Semen volume, concentration, and motility influenced the clinical pregnancy rate (CPR). Normal morphology (4%) was associated with a comparable CPR with 3%, 2%, and 1% normal forms (15.6%, 16.1%, 18.1%, and 13.1%, respectively). A combination of the total number of motile spermatozoa in the ejaculate before semen preparation (TM) at a threshold 20x10(6) was associated with a CPR of 17.8% compared to 4.6% for a threshold <20x10(6) (p<.001). Interestingly, the TM threshold to achieve satisfactory outcomes was lower (10x10(6)) in patients who had an optimal response to CC (2 dominant follicles with an endometrial thickness7mm) compared to 40x10(6) for those who had a suboptimal response (one dominant follicle with an endometrial thickness <7mm). In conclusion, the response to superovulation with CC determines each patient's TM threshold required for satisfactory outcomes. Couples whose TM is below the threshold may benefit from a superovulation with gonadotropins or in vitro fertilization.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 50 条
  • [31] PEFLOXACIN AS FIRST-LINE TREATMENT IN NEPHROTIC SYNDROME
    GINSBURG, C
    TOLEDANO, D
    DERAY, G
    VLASSOPOULOS, D
    BAUMELOU, A
    JACOBS, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (03) : 335 - 335
  • [32] Factors influencing First-Line Treatment in CLL
    Dilhuydy, Marie-Sarah
    HEMATOLOGIE, 2024, 30 : 13 - 18
  • [33] Propranolol as First-Line Treatment for Infantile Hemangiomas
    Holmes, Will J. M.
    Mishra, Anuj
    Gorst, Cath
    Liew, Se-Hwang
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2010, 125 (01) : 420 - 421
  • [34] First-line treatment for tinea capitis - Reply
    Ginter-Hanselmayer, G
    Smolle, J
    Gupta, A
    PEDIATRIC DERMATOLOGY, 2005, 22 (04) : 372 - 372
  • [35] First-line treatment of Hodgkin's lymphoma
    Klimm B.
    Engert A.
    Diehl V.
    Current Hematologic Malignancy Reports, 2006, 1 (1) : 51 - 59
  • [36] Reappraising first-line treatment in glaucoma management
    Phelan, P
    HOSPITAL MEDICINE, 2002, 63 (09): : 540 - 545
  • [37] New insights of MRgLITT :a first-line treatment?
    Venanzi, Maria Sole
    Tortora, Domenico
    Piatelli, Gianluca
    Consales, Alessandro
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2024, 34 (01)
  • [38] First-Line Treatment for Advanced Pancreatic Cancer
    Oberstein, Paul E.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2011, 12 (02): : 96 - 100
  • [39] Optimizing axitinib treatment selection following first-line sunitinib in metastatic renal cell carcinoma.
    Bracarda, Sergio
    Bamias, Aristotelis
    Casper, Jochen
    Negrier, Sylvie
    Sella, Avishay
    Staehler, Michael D.
    Tarazi, Jamal Christo
    Felici, Alessandra
    Rosbrook, Brad
    Jardinaud-Lopez, Monica
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Combination Therapy as First-Line Treatment for Hypertension
    Crawford, Michael H.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (01) : 1 - 6